| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Tianna Zhao, Lies-Anne Severijnen, Marcel van der Weiden, Ping Pin Zheng, Ben A Oostra, Renate K Hukema, Rob Willemsen, Johan M Kros, Vincenzo Bonifat. FBXO7 immunoreactivity in α-synuclein-containing inclusions in Parkinson disease and multiple system atrophy. Journal of neuropathology and experimental neurology. vol 72. issue 6. 2013-07-19. PMID:23656991. |
here, we studied fbxo7 protein expression in brain samples of normal controls (n = 9) and from patients with pd (n = 13), multiple system atrophy (msa) (n = 5), alzheimer disease (ad) (n = 5), and progressive supranuclear palsy (psp) (n = 5) using immunohistochemistry with 2 anti-fbxo7 antibodies. |
2013-07-19 |
2023-08-12 |
human |
| Richard A Armstron. Visual signs and symptoms of dementia with Lewy bodies. Clinical & experimental optometry. vol 95. issue 6. 2013-05-07. PMID:22812926. |
a combination of the clinical symptoms of alzheimer's disease and parkinson's disease is present in dlb and the disorder is classified as a 'parkinsonian syndrome', a group of diseases which also includes parkinson's disease, progressive supranuclear palsy, corticobasal degeneration and multiple system atrophy. |
2013-05-07 |
2023-08-12 |
Not clear |
| Fuyuki Tateno, Ryuji Sakakibara, Takayuki Kawai, Masahiko Kishi, Takeyoshi Muran. Alpha-synuclein in the cerebrospinal fluid differentiates synucleinopathies (Parkinson Disease, dementia with Lewy bodies, multiple system atrophy) from Alzheimer disease. Alzheimer disease and associated disorders. vol 26. issue 3. 2013-01-04. PMID:22037599. |
we examined the utility of quantification of α-synuclein (snca) in the cerebrospinal fluid (csf) to differentiate patients with alzheimer disease (ad), dementia with lewy bodies (dlb), parkinson disease (pd), and multiple system atrophy (msa). |
2013-01-04 |
2023-08-12 |
Not clear |
| Sriram Venneti, John L Robinson, Subhojit Roy, Matthew T White, Jennifer Baccon, Sharon X Xie, John Q Trojanowsk. Simulated brain biopsy for diagnosing neurodegeneration using autopsy-confirmed cases. Acta neuropathologica. vol 122. issue 6. 2012-04-10. PMID:21959586. |
postmortem tissue from the frontal, temporal and parietal cortices and basal ganglia from 73 cases including alzheimer's disease (ad), lewy body disease (lbd), frontotemporal lobar degeneration-tdp43 (ftld-tdp), multiple system atrophy (msa), pick's disease (pid), corticobasal degeneration (cbd) and progressive supranuclear palsy (psp) were evaluated using h&e and immunostains. |
2012-04-10 |
2023-08-12 |
Not clear |
| Tenshi Osawa, Yuji Mizuno, Yukio Fujita, Masamitsu Takatama, Yoichi Nakazato, Koichi Okamot. Optineurin in neurodegenerative diseases. Neuropathology : official journal of the Japanese Society of Neuropathology. vol 31. issue 6. 2012-03-16. PMID:21284751. |
however, our detailed examinations demonstrated that optineurin was found not only in als-associated pathological structures, but also in ubiquitin-positive intraneuronal inclusions in als with dementia, basophilic inclusions in the basophilic type of als, neurofibrillary tangles and dystrophic neurites in alzheimer's disease, lewy bodies and lewy neurites in parkinson's disease, ballooned neurons in creutzfeldt-jakob disease, glial cytoplasmic inclusions in multiple system atrophy, and pick bodies in pick disease. |
2012-03-16 |
2023-08-12 |
Not clear |
| Marco Onofrj, Astrid Thomas, Pietro Tiraboschi, Gregor Wenning, Francesco Gambi, Gianna Sepede, Massimo Di Giannantonio, Caterina Di Carmine, Daniela Monaco, Valerio Maruotti, Fausta Ciccocioppo, Maria Chiara D'Amico, Laura Bonann. Updates on Somatoform Disorders (SFMD) in Parkinson's Disease and Dementia with Lewy Bodies and discussion of phenomenology. Journal of the neurological sciences. vol 310. issue 1-2. 2012-02-16. PMID:21813140. |
after 2-9 years of follow up, 488 patients were labelled as pd, 415 as alzheimer disease, 162 as dlb, 48 as progressive supranuclear palsy, 48 as multiple system atrophy and 49 as fronto-temporal dementia. |
2012-02-16 |
2023-08-12 |
human |
| Edward C Lauterbach, Mario F Mende. Psychopharmacological neuroprotection in neurodegenerative diseases, part III: criteria-based assessment: a report of the ANPA committee on research. The Journal of neuropsychiatry and clinical neurosciences. vol 23. issue 3. 2012-01-25. PMID:21948886. |
despite low-to-moderate preclinical evidence scores and scant clinical evidence, the most promising investigative priorities are 1) lithium and paroxetine in alzheimer's disease (ad); 2) lithium in tauopathies (frontotemporal lobar degeneration [ftld], ftdp-17); 3) lithium-plus-valproate in ad and amyotrophic lateral sclerosis; 4) pramipexole and valproate in parkinson's disease; 5) amantadine and buspirone in multiple system atrophy; and 6) antidepressants in huntington's disease. |
2012-01-25 |
2023-08-12 |
Not clear |
| Laura K Teune, Anna L Bartels, Bauke M de Jong, Antoon T M Willemsen, Silvia A Eshuis, Jeroen J de Vries, Joost C H van Oostrom, Klaus L Leender. Typical cerebral metabolic patterns in neurodegenerative brain diseases. Movement disorders : official journal of the Movement Disorder Society. vol 25. issue 14. 2011-02-22. PMID:20669302. |
ninety-six patients could be included of which 20 patients with parkinson's disease (pd), 21 multiple system atrophy (msa), 17 progressive supranuclear palsy (psp), 10 corticobasal degeneration (cbd), 6 dementia with lewy bodies (dlb), 15 alzheimer's disease (ad), and 7 frontotemporal dementia (ftd). |
2011-02-22 |
2023-08-12 |
human |
| Katerina E Paleologou, Abid Oueslati, Gideon Shakked, Carla C Rospigliosi, Hai-Young Kim, Gonzalo R Lamberto, Claudio O Fernandez, Adrian Schmid, Fariba Chegini, Wei Ping Gai, Diego Chiappe, Marc Moniatte, Bernard L Schneider, Patrick Aebischer, David Eliezer, Markus Zweckstetter, Eliezer Masliah, Hilal A Lashue. Phosphorylation at S87 is enhanced in synucleinopathies, inhibits alpha-synuclein oligomerization, and influences synuclein-membrane interactions. The Journal of neuroscience : the official journal of the Society for Neuroscience. vol 30. issue 9. 2010-05-05. PMID:20203178. |
the levels of s87-p are increased in brains of transgenic (tg) models of synucleinopathies and human brains from alzheimer disease (ad), lb disease (lbd), and multiple system atrophy (msa) patients. |
2010-05-05 |
2023-08-12 |
human |
| Robert E Mrak, W Sue T Griffi. Common inflammatory mechanisms in Lewy body disease and Alzheimer disease. Journal of neuropathology and experimental neurology. vol 66. issue 8. 2007-10-26. PMID:17882012. |
activated microglia are found in association with alpha-synuclein-containing neurons and glia in parkinson disease, in dementia with lewy bodies, and in multiple system atrophy, and these associations are reminiscent of microglial associations with neurofibrillary tangle-containing neurons in alzheimer disease. |
2007-10-26 |
2023-08-12 |
Not clear |
| Laura Bonanni, Francesca Anzellotti, Sara Varanese, Astrid Thomas, Lamberto Manzoli, Marco Onofr. Delayed blink reflex in dementia with Lewy bodies. Journal of neurology, neurosurgery, and psychiatry. vol 78. issue 10. 2007-10-01. PMID:17878193. |
blink reflexes (br) to electric stimuli of the supraorbital nerve were recorded in 26 patients with dementia with lewy bodies (dlb), 26 patients with multiple system atrophy, 26 patients with parkinson's disease, with or without rem sleep behaviour disorder (rbd), and in 20 patients with alzheimer's disease and 20 with progressive supranuclear palsy without rbd, and compared with recordings in 30 healthy controls. |
2007-10-01 |
2023-08-12 |
Not clear |
| S Gandhi, M M K Muqit, L Stanyer, D G Healy, P M Abou-Sleiman, I Hargreaves, S Heales, M Ganguly, L Parsons, A J Lees, D S Latchman, J L Holton, N W Wood, T Reves. PINK1 protein in normal human brain and Parkinson's disease. Brain : a journal of neurology. vol 129. issue Pt 7. 2006-08-03. PMID:16702191. |
pink1 was absent in cortical lewy bodies, in neurofibrillary tangles in alzheimer's disease, progressive supranuclear palsy and corticobasal degeneration, and in the glial and neuronal alpha-synuclein positive inclusions in multiple system atrophy. |
2006-08-03 |
2023-08-12 |
human |
| Dena Hernandez, Coro Paisan Ruiz, Anthony Crawley, Roneil Malkani, John Werner, Katrina Gwinn-Hardy, Dennis Dickson, Fabienne Wavrant Devrieze, John Hardy, Andrew Singleto. The dardarin G 2019 S mutation is a common cause of Parkinson's disease but not other neurodegenerative diseases. Neuroscience letters. vol 389. issue 3. 2005-11-07. PMID:16102903. |
we screened for the most common lrrk 2 mutation in a series of patients with parkinson's disease, alzheimer's disease, progressive supranuclear palsy, multiple system atrophy and frontotemporal dementia, as well as in neurologically normal controls. |
2005-11-07 |
2023-08-12 |
Not clear |
| Masataka Nishimura, Sadako Kuno, Ryuji Kaji, Hideshi Kawakam. Brain-derived neurotrophic factor gene polymorphisms in Japanese patients with sporadic Alzheimer's disease, Parkinson's disease, and multiple system atrophy. Movement disorders : official journal of the Movement Disorder Society. vol 20. issue 8. 2005-10-19. PMID:15838855. |
brain-derived neurotrophic factor gene polymorphisms in japanese patients with sporadic alzheimer's disease, parkinson's disease, and multiple system atrophy. |
2005-10-19 |
2023-08-12 |
Not clear |
| Masataka Nishimura, Sadako Kuno, Ryuji Kaji, Hideshi Kawakam. Brain-derived neurotrophic factor gene polymorphisms in Japanese patients with sporadic Alzheimer's disease, Parkinson's disease, and multiple system atrophy. Movement disorders : official journal of the Movement Disorder Society. vol 20. issue 8. 2005-10-19. PMID:15838855. |
we studied two genetic polymorphisms (240c/t and 480g/a) of the brain-derived neurotrophic factor (bdnf) gene in japanese patients with alzheimer's disease (ad, n = 172), parkinson's disease (pd, n = 327), and multiple system atrophy (msa, n = 122), as well as controls (n = 275). |
2005-10-19 |
2023-08-12 |
Not clear |
| T H Bak, L M Crawford, V C Hearn, P S Mathuranath, J R Hodge. Subcortical dementia revisited: similarities and differences in cognitive function between progressive supranuclear palsy (PSP), corticobasal degeneration (CBD) and multiple system atrophy (MSA). Neurocase. vol 11. issue 4. 2005-10-19. PMID:16093227. |
to examine the similarities and differences in cognitive function between three predominantly subcortical dementing disorders associated with parkinsonism we compared the profiles of cognitive performance in 39 patients with progressive supranuclear palsy (psp), 26 patients with multiple system atrophy (msa) and 25 with corticobasal degeneration (cbd) with those of 30 patients with classic cortical dementia, alzheimer's disease (ad), using two different cognitive screening tests: dementia rating scale (drs) and addenbrooke's cognitive examination (ace). |
2005-10-19 |
2023-08-12 |
Not clear |
| Satoshi Orimo, Takeshi Amino, Yoshinori Itoh, Atsushi Takahashi, Tohru Kojo, Toshiki Uchihara, Kuniaki Tsuchiya, Fumiaki Mori, Koichi Wakabayashi, Hitoshi Takahash. Cardiac sympathetic denervation precedes neuronal loss in the sympathetic ganglia in Lewy body disease. Acta neuropathologica. vol 109. issue 6. 2005-10-04. PMID:15933869. |
to elucidate the extent, frequency and pattern of cardiac sympathetic nerve involvement in lewy body disease and related neurodegenerative disorders, we immunohistochemically examined heart tissues from patients with pd (n=11), dlb (n=7), dlb with alzheimer's disease (dlb/ad; n=4), multiple system atrophy (msa; n=8), progressive supranuclear palsy (psp; n=5), pure ad (n=10) and control subjects (n=5) together with sympathetic ganglia from patients with pd (n=5) and control subjects (n=4), using an antibody against tyrosine hydroxylase (th). |
2005-10-04 |
2023-08-12 |
human |
| Dominique Petit, Jean-François Gagnon, Maria Livia Fantini, Luigi Ferini-Strambi, Jacques Montplaisi. Sleep and quantitative EEG in neurodegenerative disorders. Journal of psychosomatic research. vol 56. issue 5. 2004-09-21. PMID:15172204. |
this paper reviews current knowledge on sleep problems, sleep architecture changes and quantitative eeg alteration brought on by various neurodegenerative diseases, such as alzheimer's disease (ad), progressive supranuclear palsy (psp), rem sleep behavior disorder (rbd), parkinson's disease (pd), dementia with lewy bodies (dlb), multiple system atrophy msa, huntington's disease and creutzfeldt-jakob disease, in comparison to normal aging. |
2004-09-21 |
2023-08-12 |
Not clear |
| Kenji Kadomatsu, Takashi Muramats. Midkine and pleiotrophin in neural development and cancer. Cancer letters. vol 204. issue 2. 2004-05-05. PMID:15013213. |
in addition, deposits of mk and/or ptn are found in neurodegenerative diseases, such as alzheimer's disease and multiple system atrophy. |
2004-05-05 |
2023-08-12 |
human |
| Joshua P Fessel, Christine Hulette, Suzanne Powell, L Jackson Roberts, Jing Zhan. Isofurans, but not F2-isoprostanes, are increased in the substantia nigra of patients with Parkinson's disease and with dementia with Lewy body disease. Journal of neurochemistry. vol 85. issue 3. 2003-06-17. PMID:12694390. |
in this study, we attempted to compare the levels of f2-isops and isofs esterified in phospholipids in the substantia nigra (sn) from patients with pd to those of age-matched controls as well as patients with other neurodegenerative diseases, including dementia with lewy body disease (dlb), multiple system atrophy (msa), and alzheimer's disease (ad). |
2003-06-17 |
2023-08-12 |
Not clear |